1727.5000 44.90 (2.67%)
NSE Jul 15, 2025 15:59 PM
Volume: 3.3M
 

Motilal Oswal
Sun Pharma (SUNP) reported a slight miss at the operational level for
4QFY24. This was due to lower-than-expected sales in the ROW market and
higher-than-expected opex for the quarter.
Sun Pharmaceutical Industries Ltd.'s price crossed above 50Day SMA today
More from Sun Pharmaceutical Industries Ltd.
Recommended